工业组件
Search documents
美德乐过会:今年IPO过关第82家 国泰海通过12单
Zhong Guo Jing Ji Wang· 2025-11-28 11:16
截至招股说明书签署日,张永新直接持有并控制公司46.15%的股份,为公司控股股东、实际控制 人。 美德乐本次拟在北交所向不特定合格投资者公开发行股票不超过1,600万股(不含采用超额配售选 择权发行的股票数量);公司和主承销商将根据具体发行情况择机采用超额配售选择权,采用超额配售 选择权发行的股票数量不超过本次公开发行股票数量的15%,即不超过240万股;包含采用超额配售选 择权发行的股票数量在内,本次公开发行的股票数量不超过1,840万股。 中国经济网北京11月28日讯 北京证券交易所上市委员会2025年第36次审议会议于2025年昨日上午 召开,审议结果显示,大连美德乐工业自动化股份有限公司(以下简称"美德乐")符合发行条件、上市 条件和信息披露要求。这是今年过会的第82家企业(其中,上交所和深交所一共过会47家,北交所过会 35家)。 美德乐的保荐机构为国泰海通证券股份有限公司,保荐代表人为黄祥、杨易。这是国泰海通今年保 荐成功的第12单IPO项目。此前,4月11日,国泰海通保荐的悍高集团股份有限公司首发过会;5月30 日,国泰海通保荐的海安橡胶集团股份公司首发过会;6月12日,国泰海通保荐的苏州汇川联 ...
比亚迪/宁德时代供应商美德乐北交所IPO过会,将募资6.45亿元投建4大项目
Ju Chao Zi Xun· 2025-11-28 06:36
11月27日,大连美德乐工业自动化股份有限公司(以下简称"美德乐")北交所IPO上市委会议顺利获得通过,标志着这家国内智 能输送系统领域的领军企业即将登陆资本市场,开启发展新篇章。 作为国内领先的智能输送系统供应商,大连美德乐专注于智能制造装备的研发、设计、制造和销售,核心产品包括模块化输送 系统和工业组件,其中模块化输送系统属于智能制造装备中的智能物流装备范畴。报告期内,公司业务聚焦工厂自动化领域的 智能生产物流系统,相关产品通过与智能生产设备深度融合,实现生产设备与自动化装配线的集成应用,成为智能工厂建设的 重要支撑,广泛服务于新能源、汽车零部件、电子、仓储物流等多个关键行业。 | 序号 | 项目名称 | 项目投资总额 | 募集资金投资金额 | | --- | --- | --- | --- | | | 大连美德乐四期建设项目 | 20.000.00 | 12,000.00 | | 2 | 华东工业自动化输送设备生产及研发项目 | 22.427.57 | 15.500.00 | | 3 | 高端智能化输送系统研发生产项目 | 20,000.00 | 20.000.00 | | 4 | 美德乐华南智能输送设 ...
美德乐北交所IPO过会,收入确认合规性等被追问
Bei Jing Shang Bao· 2025-11-27 13:59
北京商报讯(记者 马换换 李佳雪)11月27日晚间,北交所官网显示,大连美德乐工业自动化股份有限 公司(以下简称"美德乐")IPO当日上会获得通过。 据了解,美德乐是智能输送系统供应商,主营智能制造装备的研发、设计、制造和销售业务,主要产品 为模块化输送系统和工业组件。公司IPO于2025年5月29日获得受理,并于6月27日进入问询阶段。本次 冲击上市,公司拟募集资金约6.45亿元。 在上市委会议现场,关于收入确认合规性,上市委要求美德乐说明终端客户与集成商的验收流程存在差 异的原因,同类产品存在多种收入确认方式的合理性。 另外,上市委要求美德乐说明主要终端客户业绩下滑、新增扩建产能放缓背景下,经营业绩的稳定性及 可持续性,是否存在业绩下滑风险。 ...
美德乐IPO:募资超6亿,私募基金突击入股,实控人履历存“瑕疵”
Sou Hu Cai Jing· 2025-11-26 09:51
美德乐主营智能制造装备的研发、设计、制造和销售业务,主要产品为模块化输送系统和工业组件,业务重点聚焦应用于工厂自动化的智能生产物流系统, 广泛应用于新能源、汽车零部件、电子、仓储物流等行业领域,客户包括宁德时代、比亚迪、先导智能、长园集团等等。 梳理来看,实控人张永新表决权超46%,担任董事长、总经理职务,履历存"瑕疵";私募基金突击入股,欣旺达实控人王明旺为立夏一号第一大股东;募资 超6亿,曾分红1.25亿;募投项目投产后,预测收入接近2023年,产能消化遭问询;近两年研发人员平均薪酬大涨;研发费用率落后于行业均值;年内业绩 大涨;对比亚迪销售额存在明显波动;销售额与客户今天国际采购额存在出入;存货高企,计提比例在同行中垫底。 实控人表决权超46%,私募基金突击入股 据短平快解读了解,2009年7月,美德乐有限成立,2022年12月完成股份制改革,2024年7月挂牌新三板,目前所属层级为创新层。 实控人表决权超46%,履历存"瑕疵"。美德乐控股股东、实际控制人是张永新,直接持股比例46.15%,且担任董事长、总经理职务,能够对股东会、董事会 的会议产生重大影响。 张永新出生于1970年,毕业于上海交通大学起 ...
美德乐销售数据与客户不匹配,子公司净资产增加额超过同期净利润
Huan Qiu Wang· 2025-11-26 04:10
【环球网财经综合报道】大连美德乐工业自动化股份有限公司主要从事智能制造装备的研发、设计、制造和销售业务,主要产品 为模块化输送系统和工业组件,广泛应用于新能源、汽车零部件、电子和仓储物流等下游行业,目前该公司正在申请上市。 大连智云自动化装备股份有限公司目前的股票简称为ST智云(300097.SZ),该公司此前发布公告称因2022年年度报告存在虚假 记载,收到大连证监局《行政处罚决定书》([2025]1号),股票交易自2024年12月12日起被实施其他风险警示。 根据招股书披露,美德乐的董事会秘书为任彤,公开信息披露显示,其在2022年8月入职美德乐任董事会秘书之前,于2008年4月 至2022年7月就职于大连智云自动化装备股份有限公司,历任董事会秘书、董事、副总经理、行政委员会主任等职务。 另据《天眼查》信息显示,大连乾诚科技发展有限公司是由ST智云第二大股东谭永良担任法人代表、ST智云旗下子公司大连智云 新能源监事郑彤为第二大股东并担任经理的公司,该公司已于2023年4月注销,截至注销时,任彤仍担任该公司的董事。而此时任 彤已入职到美德乐担任董秘职务。 | 关联方名称 | 与公司关系 | 资产、人员去向 ...
大连跑出智能输送系统赛道黑马!董秘17岁参加工作 神秘股东身份成谜!
Zhong Jin Zai Xian· 2025-11-25 10:49
据北交所网站消息,北京证券交易所上市委员会定于2025年11月27日上午9时召开2025年第36次审议会 议,审议的发行人为大连美德乐工业自动化股份有限公司(简称:美德乐或者公司)。公司拟募集资金 64,500.00万元,分别用于大连美德乐四期建设项目、华东工业自动化输送设备生产及研发项目、高端智 能化输送系统研发生产项目、美德乐华南智能输送设备研发生产项目。 美德乐的保荐人、主承销商为国泰海通证券股份有限公司,签字保荐代表人为黄祥、杨易。 资料显示,发现人是国内领先的智能输送系统供应商,主营智能制造装备的研发、设计、制造和销售业 务,主要产品为模块化输送系统和工业组件。公司生产的模块化输送系统属于智能制造装备中的智能物 流装备。 在业绩方面,发行人更是无可挑剔,2022年度至2024年度及2025年上半年,美德乐营业收入分别为 10.31亿元、10.09亿元、11.38亿元和7.12亿元,净利润分别为2.24亿元、2.08亿元、2.13亿元和1.52亿 元。 分别说明各类细分产品与可比公司可比业务毛利率的差异及合理性。 这样的业绩,哪怕放在沪深交易所,也是很有说服力的,大客户更是有比亚迪、先导智能这样的大企 ...
IPO雷达丨美德乐闯关北交所,监管追问业绩波动与募投项目合理性,公司逐一回应
Sou Hu Cai Jing· 2025-11-18 08:21
深圳商报·读创客户端记者 张弛 11月17日,大连美德乐工业自动化股份有限公司(以下简称"美德乐")更新了在北京证券交易所上市申请项目动态。此前北交所第二轮审核问询将焦 点集中在美德乐的业绩变动合理性、收入确认准确性、成本核算准确性以及募投项目规模合理性等多个关键领域,美德乐针对这些问题进行了详细回 复。 美德乐回应称,验收周期延长主要受新能源电池等行业主要终端客户项目建设、投产速度放缓以及验收周期较长的客户销售占比提升的影响。公司指 出,其产品需要与其他生产设备深度融合,实现生产设备与自动化装配线的集成应用,因此联调联试周期、验收周期相对较长。 此外,美德乐还提到,公司在与部分主要客户签订合同时,会约定在终端客户对其系统整体验收通过时才发起对公司产品的验收流程,这进一步延长 了验收周期。保荐机构和申报会计师在核查后认为,美德乐的收入确认时点准确,符合《企业会计准则》的规定,与可比公司不存在显著差异。 在成本核算准确性方面,北交所关注了美德乐原材料采购、耗用与生产活动的匹配性。数据显示,报告期各期,美德乐原材料消耗金额分别占新增订 单金额的43.61%、43.72%、36.36%。北交所要求公司说明原材料采购 ...
北交所5月以来 新增受理10家公司IPO
Zhong Guo Zheng Quan Bao· 2025-06-08 21:08
Core Insights - The Beijing Stock Exchange (BSE) has seen a significant increase in IPO applications, with 10 new companies accepted since May, totaling 19 for 2025, indicating a rise in market activity and quality of projects [1][2][6] Group 1: IPO Applications and Companies - The newly accepted companies for IPO include Senhe High-Tech, Daya Co., Haisheng Medical, Yongli Precision, Medel, Yuelong Technology, and Haode CNC [1][2] - Senhe High-Tech specializes in the research, production, and sales of environmentally friendly precious metal mining agents, with projected revenues increasing from 302 million yuan in 2022 to 623 million yuan in 2024 [2] - Daya Co. focuses on metal surface treatment and ship casting, with revenues expected to rise from 1.008 billion yuan in 2022 to 1.199 billion yuan in 2024 [2] - Haisheng Medical is a leading provider of anesthesia and monitoring medical devices, with revenues projected to be around 268 million yuan in 2022 and slightly decreasing to 304 million yuan in 2024 [3] - Yongli Precision specializes in precision steel pipes for automotive applications, with revenues expected to grow from 416 million yuan in 2022 to 568 million yuan in 2024 [3] - Medel is involved in smart manufacturing equipment, with revenues projected to be around 1.031 billion yuan in 2022 and increasing to 1.138 billion yuan in 2024 [3] - Yuelong Technology focuses on flexible pipeline solutions, with revenues expected to rise from 189 million yuan in 2022 to 262 million yuan in 2024 [4] - Haode CNC provides specialized equipment for panel furniture, with revenues projected to be around 337 million yuan in 2022 and slightly decreasing to 458 million yuan in 2024 [4] Group 2: Specialized "Little Giant" Enterprises - Zhigao Machinery and Shichang Co. are recognized as specialized "little giant" enterprises, successfully passing the IPO review [5][6] - Zhigao Machinery, focusing on rock drilling equipment, expects revenues to grow from 795 million yuan in 2022 to 888 million yuan in 2024, with an IPO fundraising target of 395 million yuan [5] - Shichang Co. specializes in automotive fuel systems, with projected revenues increasing from 282 million yuan in 2022 to 515 million yuan in 2024, aiming to raise 171 million yuan through its IPO [6] Group 3: Market Activity and Future Outlook - The BSE has experienced heightened market activity, with a notable increase in the quality of IPO projects and growing market recognition and participation [1][6] - The subscription for new shares remains robust, exemplified by the recent IPO of Jiaoda Tefa, which saw an oversubscription rate of 3234.41 times [6] - The future outlook suggests that high-quality expansion and a diversified product system will further enhance market liquidity [1][6]
美德乐冲刺北交所:比亚迪订单骤降,第一大客户业绩也承压,客户高度集中隐忧下能否过关?
Mei Ri Jing Ji Xin Wen· 2025-06-04 14:59
Core Viewpoint - Dalian Meidel Industrial Automation Co., Ltd. (Meidel) is planning to list on the Beijing Stock Exchange after previously aiming for the Shenzhen Stock Exchange, amid declining revenue and net profit due to high customer concentration risks [1][2]. Group 1: Company Performance - In 2023, Meidel's revenue and net profit both declined, with revenues of 1.031 billion yuan in 2022, 1.009 billion yuan in 2023, and projected 1.138 billion yuan in 2024. Net profits were 222 million yuan, 205 million yuan, and 211 million yuan for the same years [4][5]. - The company's largest customer, BYD, saw its sales contribution drop from nearly 50% in 2022 to 10.25% in 2024, with sales amounts decreasing from 509 million yuan to 117 million yuan [5][7]. - The concentration of sales to the top five customers was 59.34% in 2022, 51.29% in 2023, and 47.50% in 2024, indicating a high dependency on a few clients [5][6]. Group 2: Customer Dynamics - The new largest customer, Xian Dao Intelligent, is also facing performance pressures, with revenue and net profit declining by 28.71% and 83.88% respectively in 2024, and further declines in the first quarter of 2024 [7]. - Despite the challenges faced by major clients, Meidel claims to have a stable customer base and strong brand recognition, which helps maintain customer loyalty [7][6]. - The company is expanding its market presence and diversifying its customer base, which is expected to reduce customer concentration risks over time [6][5]. Group 3: Strategic Adjustments - The decision to shift the listing target from the Shenzhen Stock Exchange to the Beijing Stock Exchange was based on the company's operational situation and strategic planning, in consultation with advisory institutions [2]. - The company's major shareholders include Zhang Yongxin, who holds 46.15% of the shares, and Chen Libo, who holds 22.99%, with Zhang recognized as the controlling shareholder [2][3].
北交所1天受理3家IPO
梧桐树下V· 2025-05-30 01:30
Group 1: IPO Applications - Beijing Stock Exchange accepted three IPO applications on May 29, 2025: Dalian Meidele (874489), Zhejiang Yongli Precision (874457), and Zhejiang Haiseng Medical (873794) [1] - As of now, a total of 12 companies have submitted IPO applications to the Beijing Stock Exchange in 2025 [1] Group 2: Dalian Meidele Industrial Automation Co., Ltd. - Dalian Meidele is a national high-tech enterprise specializing in the research, design, manufacturing, and sales of intelligent manufacturing equipment, primarily modular conveyor systems and industrial components [4] - The company has a registered capital of 56.123 million yuan and plans to list on the New Third Board on July 19, 2024 [3] - In 2024, the company expects to achieve a net profit of over 200 million yuan, with revenues of 1.138 billion yuan, and a net profit margin of 33.60% [6][7] - The company has a high customer concentration, with BYD being a major client, contributing 10.25% of total revenue in 2024 [9][10] - The IPO aims to raise 645 million yuan for four projects, including the construction of a new facility and R&D projects [12] Group 3: Zhejiang Yongli Precision Manufacturing Co., Ltd. - Zhejiang Yongli Precision focuses on the R&D, production, and sales of precision steel pipes and components for automotive applications, with a registered capital of 60 million yuan [14] - The company expects a net profit of 92.13 million yuan in 2024, with revenues projected at 568 million yuan [18][20] - The company has a high customer concentration, with BYD being the second-largest client in 2023 and 2024 [22][23] - The IPO plans to raise 380 million yuan for two projects, including the expansion of production capacity for chassis systems [26] Group 4: Zhejiang Haiseng Medical Device Co., Ltd. - Zhejiang Haiseng Medical specializes in the R&D, production, and sales of anesthesia and monitoring medical devices, with a registered capital of 64 million yuan [27] - The company anticipates a net profit of 68.04 million yuan in 2024, with revenues of approximately 304 million yuan [30][31] - The company has a low customer concentration, with the top five clients contributing only 21.66% of total revenue in 2024 [33] - The IPO aims to raise approximately 370.4 million yuan for three projects [34]